News

AlphaGalileo3h
Amylin Administration Exacerbates Tauopathy by Impairing Lysosomal Mechanisms in a Hybrid Diabetes Model
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
A new model enables drug discovery for a disorder affecting 40 people worldwide
Researchers at the Gray Faculty of Medical and Health Sciences at Tel Aviv University have developed a model that accurately ...
The Jewish Press1d
Researchers at Tel Aviv University Develop Groundbreaking Model for Rare Genetic Disease
Prof. Moran Hausman-Kedem, a pediatric neurologist involved in the research, emphasized the clinical value of the model: “For rare diseases where patient populations are too small for large-scale ...
News-Medical.Net6d
New pretreatment method boosts islet transplant survival in diabetes
A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a ...
Small molecule treatment could make islet transplantation therapy more effective
A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a ...
MTVA: DA-1241 in Combination with Efruxifermin Shows Additive Hepatoprotective Effects in Mouse MASH Model…
MTVA READ THE FULL MTVA RESEARCH REPORT Business Update DA-1241 in Combination with Efruxifermin Shows Enhanced ...
Drug Delivery Business6d
Modular Medical study shows potential benefits of pump-delivered GLP-1s
(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.